ACCESS GROWTH CAPITAL THROUGH THE PUBLIC MARKETS

TSX and TSX Venture Exchange list leading public Life Sciences companies from Canada and around the world.

Daniel Lubienietzky

Daniel Lubienietzky

Manager, Life Sciences

LIFE SCIENCES Updates

A collection of videos focused on insights for accessing growth capital through the public markets with industry experts.

KEY BENEFITS FOR LIFE SCIENCES COMPANIES

  • 1
    Access To Capital And Future Financing Opportunities
    Going public can provide your company with financing opportunities to grow your business while expanding and diversifying your investor base by giving you access to pools of capital in Canada, the U.S. and globally.
  • 2
    Facilitate Growth
    As a public company, your shares can be used as a currency substitute to acquire target companies, instead of a direct cash offering.
  • 3
    Increase Visibility And Prestige
    Going public enhances your company’s visibility which can provide your company with a higher profile and greater credibility.
  • 4
    Provide Liquidity For Shareholders
    Becoming a public company establishes a market for your company’s shares, providing your investors with an efficient and regulated vehicle in which to trade their shares.
  • 5
    Create Employee Incentive Mechanisms
    Your employees can participate in the ownership of your company and benefit from being shareholders. This can serve to ensure stronger employee commitment to your company’s performance and success.

$52.8 billion

Life Sciences market capitalization

51%

of Life Sciences companies currently listed on TSX are graduates
GET MORE INFORMATION

WHY GO PUBLIC?

CAPITAL SOLUTIONS

For early-stage companies looking to gain access to public venture capital - or larger, established companies looking to take their business to the next level, going public may be the right fit for your company. Our two-tiered market offers financing and liquidity solutions that can be as unique as the businesses it serves.

GO PUBLIC - WAYS TO GET LISTED

There are multiple pathways to listing on TSX and TSXV.

TSX and TSXV Listed company initiatives

TSX30

The TSX30 is a ranking of the top 30 performers on the Toronto Stock Exchange, over a three-year period based on dividend-adjusted share price appreciation.

As an annual flagship recognition program for TSX’s top performers to provide insights into the broad market trends that have been driving the best returns for investors, the TSX30 tells an important story; there is value in looking at the performance of small and mid-cap companies across TSX.

TSX VENTURE 50

The TSX Venture 50 is a ranking of the top ten performers on the TSX Venture Exchange over the last year, comprising of 10 companies from five industry sectors.

This annual program showcases the top performing listed companies from five industry sectors, including: Clean Technology and Life Sciences, Diversified Industries, Energy, Mining, and Technology. Selection is based on 3 equally weighted criteria: share price appreciation, trading volume, and market capitalization growth.

The key benefit of this two-tiered market (TSX Venture and TSX) is the potential for early-stage growth companies to list on TSXV, grow and when ready, graduate to TSX. Nearly 36% of current TSX-listed technology companies started on TSXV.

Life Sciences Statistics

19

new Life Sciences listings
in H1 2021

$2.2 billion

raised in Life Sciences
in H1 2021

94

financings in Life Sciences
in H1 2021

All data as of June 30, 2021 unless otherwise noted.

Market Intelligence Report (MiG)

Provides year-to-date data on listings, financings and trading activity across Toronto Stock Exchange and TSX Venture Exchange, broken down by sector and region.

GET OUR MIG REPORT

LEARN ABOUT TSX AND TSXV

WHAT INDUSTRY EXPERTS ARE SAYING
TMX POV - Canadian Life Sciences Market is Alive and Flourishing
In many ways, 2020 started out quite optimistically for Canadian markets -- according to Statistics Canada unemployment was at a five-year low of 5.6% at the end of 2019 and the S&P/TSX Composite Index* had a very robust 22% return from the previous year. All signs seemed to point to continued momentum into 2020.
Read more

More Info

Dual-Listing Guide

Dual-Listing Guide

A detailed guide for public companies looking to dual list.

2021 Guide to Listing

2021 Guide to Listing

Market overview, listing requirements & vehicles, and sector profiles.

Technical Guide

Technical Guide

A more detailed guide to listing on TSX and TSXV.